# SIMBRINZA

NDC: 0065-4147
Generic name: brinzolamide/brimonidine tartrate
Labeler / Manufacturer: Alcon Laboratories, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SUSPENSION/ DROPS
Routes: OPHTHALMIC
Marketing started: 20130506

FDA application: NDA204251

## Active ingredients

- BRIMONIDINE TARTRATE: 2 mg/mL
- BRINZOLAMIDE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0065-4147"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0065-4147
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a49c157e-6310-0011-7b7f-e26fc1820d59